Ingredient
P-Hydroxyanisole
P-Hydroxyanisole is flagged for pregnancy, breastfeeding and trying to conceive. The concern behind the strongest flag is absorbed into the body.
- 4-Methoxyphenol
- Mequinol
- Hydroquinone Monomethyl Ether
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 3 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
P-Hydroxyanisole and pregnancy
Caution Advised
- Absorbed into the body
P-Hydroxyanisole is a phenolic compound chemically related to hydroquinone, used as an antioxidant in cosmetics and as a skin-lightening agent in pharmaceutical products. It works by inhibiting melanin production. While specific pregnancy studies on p-hydroxyanisole are limited, its structural similarity to hydroquinone raises concerns. Hydroquinone is avoided during pregnancy due to high systemic absorption rates (35-45%). Though p-hydroxyanisole appears to have lower absorption, data is insufficient to confirm safety during pregnancy. When used in prescription combination products with tretinoin, the tretinoin component is contraindicated in pregnancy. Most dermatologists recommend avoiding skin-lightening agents during pregnancy due to uncertain safety profiles and the availability of safer alternatives. Melasma is common during pregnancy but often resolves postpartum, making treatment delay a reasonable approach.
P-Hydroxyanisole and breastfeeding
Caution Advised
- Absorbed into the body
- Infant exposure
P-Hydroxyanisole is a hydroquinone derivative used for skin brightening and as an antioxidant. Its potential for systemic absorption and transfer to breast milk has not been adequately studied. Given its chemical similarity to hydroquinone, which is avoided during breastfeeding due to systemic absorption concerns, p-hydroxyanisole should be used cautiously. While it may have lower absorption than hydroquinone, definitive data is lacking. Phenolic compounds can potentially be absorbed and distributed systemically. The AAD recommends postponing elective skin-lightening treatments until after breastfeeding when safer alternatives can be used. If treatment is necessary, ingredients with more established safety profiles during lactation would be preferable.
P-Hydroxyanisole and postpartum
Safe to Use
- Irritant
- Increases sun sensitivity
For postpartum women not breastfeeding, p-hydroxyanisole may be used to address melasma and hyperpigmentation that developed during pregnancy. It provides brightening benefits with potentially less irritation than hydroquinone. The main concerns are skin irritation and photosensitivity, which can be managed with proper use of sunscreen. This ingredient may be helpful for treating pregnancy-related melasma, though consistent sun protection is essential during treatment.
P-Hydroxyanisole and trying to conceive
Caution Advised
- Absorbed into the body
Women trying to conceive should consider discontinuing p-hydroxyanisole as a precautionary measure, given its structural similarity to hydroquinone and limited safety data in pregnancy. While no specific fertility concerns have been identified, the recommendation to avoid during pregnancy extends to the preconception period. Safer alternatives for skin brightening are available during this time.
P-Hydroxyanisole and PCOS
Safe to Use
P-Hydroxyanisole has no known hormonal activity and does not affect androgen levels or insulin sensitivity. It can be used safely for treating hyperpigmentation that may occur with PCOS-related acne. For those with PCOS-related acne scarring or post-inflammatory hyperpigmentation, this antioxidant may provide brightening benefits without hormonal interference. This ingredient is safe for use with PCOS. The main considerations are the same as for general use: potential irritation and the need for sun protection.
P-Hydroxyanisole and general use
Safe to Use
- Irritant
- Increases sun sensitivity
P-Hydroxyanisole serves as both an antioxidant and skin-brightening agent in cosmetics. It's considered a gentler alternative to hydroquinone with similar but less potent effects on melanin production. The EU restricts its use to 0.1% as an antioxidant in cosmetics. In the US, it's found in a prescription product (Solage) combined with tretinoin for treating age spots. Users should be aware of potential skin irritation and increased sun sensitivity. When used appropriately with sun protection, p-hydroxyanisole can be effective for treating hyperpigmentation with a potentially better safety profile than hydroquinone. However, those with sensitive skin should patch test and introduce gradually.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of P-Hydroxyanisole, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store